{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:26:11Z","timestamp":1787502371413,"version":"build-2736575974"},"reference-count":36,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2021013"],"award-info":[{"award-number":["2021013"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018336","name":"National Institute for Health Research Health Protection Research Unit","doi-asserted-by":"publisher","award":["NIHR200915"],"award-info":[{"award-number":["NIHR200915"]}],"id":[{"id":"10.13039\/100018336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,5,28]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We investigated the epidemiology and impact on mortality of antimicrobial resistance (AMR) in cancer patients with bacteraemia at Oxford University Hospitals (OxUH), UK, and Oslo University Hospital (OsUH), Norway, during 2008\u20132018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Historical cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Regional hospital trusts with multiple sites in OxUH and OsUH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with cancer and blood cultures positive for one of six pathogen groups during a hospital stay within 3 years following their first cancer diagnosis were followed for 30 days after their first bacteraemia episode. We determined the number of cases and the proportion of infections with an AMR phenotype. Excess mortality and the population-attributable fraction (PAF) due to AMR were estimated by contrasting observed mortality at the end of follow-up with an estimated counterfactual scenario where AMR was absent from all bacteraemias, using inverse probability weighting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measure<\/jats:title>\n                    <jats:p>30-day all-cause mortality following the first bacteraemia episode.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main exposure measure<\/jats:title>\n                    <jats:p>A resistant phenotype of the causative pathogen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 1929 patients at OxUH and 1640 patients at OsUH. The highest resistance proportions were found for vancomycin resistance in enterococci (85\/314, 27.1%) and carbapenem-resistance in\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      (63\/260, 24.2%) at OxUH, and third-generation cephalosporin resistance in\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (62\/743, 8.3%) and\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      (14\/223, 6.3%) at OsUH. Observed mortality for all infections was 26.4% at OxUH, with an estimated counterfactual mortality without AMR of 24.7%, yielding an excess mortality of 1.7% (95% CI: 0.8 to 2.5%). The PAF was 6.3% (95% CI: 2.9 to 9.6%), meaning an estimated 32 of 509 deaths could be attributed to AMR. Limited events at OsUH precluded a similar estimate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite estimating modest excess mortality, the mortality attributable to resistance in these two high-income, low-prevalence settings highlights the potential for escalation if global resistance trends continue to worsen.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-092740","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T04:05:51Z","timestamp":1750046751000},"page":"e092740","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiology and excess mortality of antimicrobial resistance in bacteraemias among cancer patients: a cohort study using routinely collected health data from regional hospital trusts in Oxford and Oslo, 2008\u20132018"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2006-2260","authenticated-orcid":false,"given":"Anders Skyrud","family":"Danielsen","sequence":"first","affiliation":[{"name":"Department of Microbiology, Oslo University Hospital, Oslo, Norway"},{"name":"Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherry","family":"Lim","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"},{"name":"Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Ho","family":"Yoon","sequence":"additional","affiliation":[{"name":"Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-4969","authenticated-orcid":false,"given":"Jon Michael","family":"Gran","sequence":"additional","affiliation":[{"name":"Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kacelnik","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5095-6367","authenticated-orcid":false,"given":"David W.","family":"Eyre","sequence":"additional","affiliation":[{"name":"Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK"},{"name":"NIHR Oxford Biomedical Research Centre, Oxford, UK"},{"name":"NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0079-8062","authenticated-orcid":false,"given":"J\u00f8rgen Vildersh\u00f8j","family":"Bj\u00f8rnholt","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Oslo University Hospital, Oslo, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"2025081404581624000_15.6.e092740.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0\/ATTACHMENT\/4504FC2B-08AE-46D6-BD75-80811DF8B5E6\/MMC1.PDF"},{"key":"2025081404581624000_15.6.e092740.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-099(18)30605-4"},{"key":"2025081404581624000_15.6.e092740.3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.cmi.2023.09.001","article-title":"A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe","volume":"30 Suppl 1","author":"Hassoun-Kheir","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2025081404581624000_15.6.e092740.4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmi.2016.01.023","article-title":"Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections","volume":"22","author":"Hauck","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2025081404581624000_15.6.e092740.5","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac305","article-title":"Excess Mortality Attributable to Hospital-Acquired Antimicrobial-Resistant Infections: A 2-Year Prospective Surveillance Study in Northeast Thailand","volume":"9","author":"Lim","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2025081404581624000_15.6.e092740.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30485-0"},{"key":"2025081404581624000_15.6.e092740.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2014.11.015"},{"key":"2025081404581624000_15.6.e092740.8","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1016\/S1473-3099(19)30276-2","article-title":"Improving the estimation of the global burden of antimicrobial resistant infections","volume":"19","author":"Limmathurotsakul","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2025081404581624000_15.6.e092740.9","doi-asserted-by":"crossref","unstructured":"Zembower TR . Epidemiology of infections in cancer patients. In: Stosor V , Zembower TR , eds. Infect. Complicat. Cancer Patients. Cham: Springer International Publishing, 2014: 43\u201389. Available: https:\/\/doi.org\/10.1007\/978-3-319-04220-6_2","DOI":"10.1007\/978-3-319-04220-6_2"},{"key":"2025081404581624000_15.6.e092740.10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40121-017-0146-1","article-title":"Infections in Cancer Patients with Solid Tumors: A Review","volume":"6","author":"Rolston","year":"2017","journal-title":"Infect Dis Ther"},{"key":"2025081404581624000_15.6.e092740.11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.idc.2019.02.011","article-title":"Bacterial Infections in the Stem Cell Transplant Recipient and Hematologic Malignancy Patient","volume":"33","author":"Misch","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"2025081404581624000_15.6.e092740.12","unstructured":"The European Committee on Antimicrobial Susceptibility Testing . Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0, 2024. Available: http:\/\/www.eucast.org"},{"key":"2025081404581624000_15.6.e092740.13","unstructured":"Hern\u00e1n MA , Robins JM . Causal Inference: What If. Boca Raton: Chapman & Hall\/CRC, 2020."},{"key":"2025081404581624000_15.6.e092740.14","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/asm097"},{"key":"2025081404581624000_15.6.e092740.15","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2607"},{"key":"2025081404581624000_15.6.e092740.16","unstructured":"R Core Team . R: a language and environment for statistical computing. Vienna, Austria, 2023."},{"key":"2025081404581624000_15.6.e092740.17","unstructured":"ResCan-mortality . Analyses.Rmd at main andersskyrud\/ResCan-mortality. GitHub, Available: https:\/\/github.com\/andersskyrud\/ResCan-mortality\/blob\/main\/Analyses.Rmd"},{"key":"2025081404581624000_15.6.e092740.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211741","article-title":"vancomycin resistant enterococci (VRE) and methicillin resistant Staphylococcus aureus (MRSA) in Norway, 2006 - 2017","volume":"14","author":"Elstr\u00f8m","year":"2019","journal-title":"PLoS ONE"},{"key":"2025081404581624000_15.6.e092740.19","unstructured":"NORM\/NORM-VET 2022 . Usage of antimicrobial agents and occurrence of antimicrobial resistance in norway. troms\u00f8 \/ oslo. 2023."},{"key":"2025081404581624000_15.6.e092740.20","unstructured":"UK Health Security Agency . English surveillance programme for antimicrobial utilisation and resistance (espaur) report 2022 to 2023. London UK Health Security Agency; 2023."},{"key":"2025081404581624000_15.6.e092740.21","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-023-04698-3"},{"key":"2025081404581624000_15.6.e092740.22","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks082"},{"key":"2025081404581624000_15.6.e092740.23","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000608"},{"key":"2025081404581624000_15.6.e092740.24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00355-19","article-title":"The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program","volume":"63","author":"Diekema","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2025081404581624000_15.6.e092740.25","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.3201\/eid2911.230753","article-title":"Systematic Review and Meta-analysis of Deaths Attributable to Antimicrobial Resistance, Latin America","volume":"29","author":"Ciapponi","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"2025081404581624000_15.6.e092740.26","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-018-0336-y","article-title":"Estimating the burden of antimicrobial resistance: a systematic literature review","volume":"7","author":"Naylor","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"2025081404581624000_15.6.e092740.27","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00233-5"},{"key":"2025081404581624000_15.6.e092740.28","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00059-12"},{"key":"2025081404581624000_15.6.e092740.29","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac189"},{"key":"2025081404581624000_15.6.e092740.30","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwab158"},{"key":"2025081404581624000_15.6.e092740.31","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30477-1"},{"key":"2025081404581624000_15.6.e092740.32","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0795-y"},{"key":"2025081404581624000_15.6.e092740.33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24812"},{"key":"2025081404581624000_15.6.e092740.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.04.014"},{"key":"2025081404581624000_15.6.e092740.35","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxab001"},{"key":"2025081404581624000_15.6.e092740.36","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/cid\/ciz414","article-title":"Zero or More: Methodological Challenges of Counting and Estimating Deaths Related to Antibiotic-resistant Infections","volume":"69","author":"Temkin","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-092740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T14:28:28Z","timestamp":1755181708000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-092740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,13]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bmjopen-2024-092740"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-092740","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.21.24312363","asserted-by":"object"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}